Ubiquitination and the Proteasome as Drug Targets in Trypanosomatid Diseases
The eukaryotic pathogens Trypanosoma brucei, Trypanosoma cruzi and Leishmania are responsible for debilitating diseases that affect millions of people worldwide. The numbers of drugs available to treat these diseases, Human African Trypanosomiasis, Chagas' disease and Leishmaniasis are very lim...
Main Author: | Marie-José Bijlmakers |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-01-01
|
Series: | Frontiers in Chemistry |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fchem.2020.630888/full |
Similar Items
-
Exploration fonctionnelle de protéines mitochondriales et étude du protéasome 'mitochondrial' HslVU, cible thérapeutique potentielle, chez les Trypanosomatidés.
by: Mbang-Benet, Diane-Ethna
Published: (2012) -
Trypanosomatid Aquaporins: Roles in Physiology and Drug Response
by: Goutam Mandal, et al.
Published: (2013-12-01) -
Of Drugs and Trypanosomatids: New Tools and Knowledge to Reduce Bottlenecks in Drug Discovery
by: Arijit Bhattacharya, et al.
Published: (2020-06-01) -
An affinity-directed protein missile system for targeted proteolysis
by: Luke J. Fulcher, et al.
Published: (2016-01-01) -
Autophagy in Trypanosomatids
by: Paul A. M. Michels, et al.
Published: (2012-07-01)